NeuroTrauma Sciences
PrivateCompany Overview
NeuroTrauma Sciences operates in Healthcare & Life Sciences and is based in Alpharetta, Georgia. It was founded in 2016.
NeuroTrauma Sciences is a biopharmaceutical company that was focused on developing drugs for the treatment of brain and neurological injuries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroTrauma Sciences Comparables
Compare NeuroTrauma Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astrocyte Pharmaceuticals Inc. | 86% | |
| NoNO Inc. | 81% | |
| Nyrada Inc | 79% |
For institutional investors. Book with your work email.
NeuroTrauma Sciences Funding Rounds
Historical fundraising activity
NeuroTrauma Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroTrauma Sciences's valuation, stock price, and market status.
Is NeuroTrauma Sciences a public or private company?
NeuroTrauma Sciences is a private company.
What is the current stock price of NeuroTrauma Sciences?
NeuroTrauma Sciences is a private company, so its shares have no public market price. Caplight tracks NeuroTrauma Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroTrauma Sciences worth (valuation)?
Valuation information for NeuroTrauma Sciences is not publicly available.
Can I buy NeuroTrauma Sciences stock?
NeuroTrauma Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroTrauma Sciences's last funding round?
Funding round information for NeuroTrauma Sciences is not publicly available.
Who are the main investors in NeuroTrauma Sciences?
Investor information for NeuroTrauma Sciences is not publicly disclosed.
Will NeuroTrauma Sciences IPO soon?
No public IPO plans have been announced for NeuroTrauma Sciences.
How can I track NeuroTrauma Sciences secondary market activity?
Caplight tracks bids, offers, and trades in NeuroTrauma Sciences's shares on secondary markets.